Skip to Content

54 Results Found

  • Review
  • Open Access
22 Citations
6,925 Views
8 Pages

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in more than 16 million infections and more than 600,000 deaths worldwide. There is an urgent need to develop a safe and effective vaccine against SARS-CoV-2....

(This article belongs to the Section Vaccines and Therapeutic Developments)
  • Review
  • Open Access
127 Citations
18,880 Views
15 Pages

4 July 2016

Viral vaccine vectors have shown to be effective in inducing a robust immune response against the vaccine antigen. Newcastle disease virus (NDV), an avian paramyxovirus, is a promising vaccine vector against human and veterinary pathogens. Avirulent...

(This article belongs to the Special Issue Replication-Competent Reporter-Expressing Viruses)
  • Review
  • Open Access
53 Citations
11,147 Views
24 Pages

It has been 20 years since Newcastle disease virus (NDV) was first used as a vector. The past two decades have witnessed remarkable progress in vaccine generation based on the NDV vector and optimization of the vector. Protective antigens of a variet...

(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)
  • Review
  • Open Access
38 Citations
9,110 Views
12 Pages

26 March 2019

Highly pathogenic avian influenza (HPAI) and Newcastle disease are economically important avian diseases worldwide. Effective vaccination is critical to control these diseases in poultry. Live attenuated Newcastle disease virus (NDV) vectored vaccine...

(This article belongs to the Special Issue Avian Respiratory Viruses)
  • Article
  • Open Access
30 Citations
11,663 Views
16 Pages

Newcastle Disease Virus Vectored Bivalent Vaccine against Virulent Infectious Bursal Disease and Newcastle Disease of Chickens

  • Sohini Dey,
  • Madhan Mohan Chellappa,
  • Dinesh C. Pathak,
  • Satish Gaikwad,
  • Kalpana Yadav,
  • Saravanan Ramakrishnan and
  • Vikram N. Vakharia

26 September 2017

Newcastle disease virus (NDV) strain F is a lentogenic vaccine strain used for primary vaccination in day-old chickens against Newcastle disease (ND) in India and Southeast Asian countries. Recombinant NDV-F virus and another recombinant NDV harborin...

  • Article
  • Open Access
5 Citations
2,148 Views
19 Pages

Newcastle Disease Virus-Vectored African Swine Fever Virus Antigen Cocktail Delays the Onset of ASFV-SY18 but Is Not Protective

  • Qian Li,
  • Yiqian Jiang,
  • Min Zheng,
  • Xuefei Sun,
  • Lili Hui,
  • Yanyan Zhang,
  • Huixian Yue,
  • Yu Qi,
  • Siqi Li and
  • Rongliang Hu
  • + 11 authors

African Swine Fever (ASF) is a highly contagious viral disease threatening the global pig industry. Currently, only two gene-deleted live attenuated vaccines are approved, exclusively in Vietnam, and their long-term effectiveness and safety are unpro...

(This article belongs to the Section Virology)
  • Review
  • Open Access
29 Citations
8,949 Views
17 Pages

The Application of Newcastle Disease Virus (NDV): Vaccine Vectors and Tumor Therapy

  • Huiming Yang,
  • Jiaxin Tian,
  • Jing Zhao,
  • Ye Zhao and
  • Guozhong Zhang

30 May 2024

Newcastle disease virus (NDV) is an avian pathogen with an unsegmented negative-strand RNA genome that belongs to the Paramyxoviridae family. While primarily pathogenic in birds, NDV presents no threat to human health, rendering it a safe candidate f...

(This article belongs to the Special Issue Newcastle Disease and Other Avian Orthoavulaviruses 1)
  • Article
  • Open Access
16 Citations
5,666 Views
25 Pages

A Novel Recombinant Newcastle Disease Virus Vectored DIVA Vaccine against Peste des Petits Ruminants in Goats

  • Magdalena Murr,
  • Bernd Hoffmann,
  • Christian Grund,
  • Angela Römer-Oberdörfer and
  • Thomas C. Mettenleiter

28 April 2020

Peste des petits ruminants virus (PPRV, species: small ruminant morbillivirus) is the causative agent of the eponymous notifiable disease, the peste des petits ruminants (PPR) in wild and domestic sheep and goats. Mortality rates vary between 50% and...

(This article belongs to the Section Vaccine Design, Development, and Delivery)
  • Article
  • Open Access
4 Citations
3,577 Views
13 Pages

Chimeric Newcastle Disease Virus Vectors Expressing Human IFN-γ Mediate Target Immune Responses and Enable Multifaceted Treatments

  • Rofaida Mostafa Soliman,
  • Keisuke Nishioka,
  • Tomo Daidoji,
  • Osamu Noyori and
  • Takaaki Nakaya

The therapeutic potential of Newcastle disease virus (NDV) has been reported as both an oncolytic agent and a vaccine vector against many antigens. However, in the individuals already immunized with NDVs, second and subsequent administration does not...

(This article belongs to the Section Immunology and Immunotherapy)
  • Abstract
  • Open Access
2,026 Views
1 Page

Many Newcastle disease virus (NDV) strains have been developed as vectors to express a foreign gene (FG) for vaccine and gene therapy purposes. A majority of these NDV vectors express only a single FG or two FGs from suboptimal insertion sites in the...

(This article belongs to the Proceedings of Viruses 2020—Novel Concepts in Virology)
  • Article
  • Open Access
9 Citations
6,077 Views
21 Pages

Intranasally Delivered Adenoviral Vector Protects Chickens against Newcastle Disease Virus: Vaccine Manufacturing and Stability Assessments for Liquid and Lyophilized Formulations

  • Omar Farnós,
  • Barbara Cristina Martins Fernandes Paes,
  • Belayneh Getachew,
  • Samia Rourou,
  • Ameni Chaabene,
  • Esayas Gelaye,
  • Takele A. Tefera and
  • Amine A. Kamen

29 December 2023

Newcastle disease (ND) remains a critical disease affecting poultry in sub-Saharan Africa. In some countries, repeated outbreaks have a major impact on local economies and food security. Recently, we developed an adenovirus-vectored vaccine encoding...

(This article belongs to the Special Issue Bioengineering in Vaccine Design and Delivery)
  • Article
  • Open Access
13 Citations
8,217 Views
24 Pages

Developing vaccine technology platforms to respond to pandemic threats or zoonotic diseases is a worldwide high priority. The risk of infectious diseases transmitted from wildlife and domestic animals to humans makes veterinary vaccination and animal...

(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)
  • Article
  • Open Access
15 Citations
6,247 Views
15 Pages

A Herpesvirus of Turkey-Based Vector Vaccine Reduces Transmission of Newcastle Disease Virus in Commercial Broiler Chickens with Maternally Derived Antibodies

  • Timea Tatár-Kis,
  • Egil A.J. Fischer,
  • Christophe Cazaban,
  • Edit Walkó-Kovács,
  • Zalan G. Homonnay,
  • Francisca C. Velkers,
  • Vilmos Palya and
  • J. Arjan Stegeman

16 October 2020

Newcastle Disease is one of the most important infectious poultry diseases worldwide and is associated with high morbidity, mortality, and economic loss. In several countries, vaccination is applied to prevent and control outbreaks; however, informat...

(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)
  • Abstract
  • Open Access
2,043 Views
1 Page

Protection of Chickens with Maternal Avian Influenza Virus (AIV) Immunity after Vaccination with a Recombinant AIV-Newcastle Disease Vector

  • Magdalena Murr,
  • Olayinka Asala,
  • Axel Karger,
  • Christian Grund,
  • Thomas C. Mettenleiter and
  • Angela Römer-Oberdörfer

Highly pathogenic avian influenza virus (HPAIV) belongs to the Orthomyxoviridae family and causes a systemic and highly lethal disease in poultry. Vaccination with recombinant Newcastle disease vector viruses (NDV) expressing the hemagglutinin (HA) o...

(This article belongs to the Proceedings of Viruses 2020—Novel Concepts in Virology)
  • Article
  • Open Access
12 Citations
4,147 Views
11 Pages

11 February 2023

Infectious laryngotracheitis (ILT) and Newcastle disease (ND) are two important avian diseases that have caused huge economic losses to the poultry industry worldwide. Newcastle disease virus (NDV) has been used as a vector in the development of vacc...

(This article belongs to the Special Issue Avian Respiratory Viruses, Volume III)
  • Feature Paper
  • Article
  • Open Access
4 Citations
4,886 Views
14 Pages

The Expression of Hemagglutinin by a Recombinant Newcastle Disease Virus Causes Structural Changes and Alters Innate Immune Sensing

  • Fiona Ingrao,
  • Victoria Duchatel,
  • Isabel Fernandez Rodil,
  • Mieke Steensels,
  • Eveline Verleysen,
  • Jan Mast and
  • Bénédicte Lambrecht

Recombinant Newcastle disease viruses (rNDV) have been used as bivalent vectors for vaccination against multiple economically important avian pathogens. NDV-vectored vaccines expressing the immunogenic H5 hemagglutinin (rNDV-H5) are considered attrac...

(This article belongs to the Special Issue Poultry Vaccines)
  • Article
  • Open Access
23 Citations
6,887 Views
15 Pages

A Recombinant La Sota Vaccine Strain Expressing Multiple Epitopes of Infectious Bronchitis Virus (IBV) Protects Specific Pathogen-Free (SPF) Chickens against IBV and NDV Challenges

  • Lei Tan,
  • Guoyuan Wen,
  • Xusheng Qiu,
  • Yanmei Yuan,
  • Chunchun Meng,
  • Yingjie Sun,
  • Ying Liao,
  • Cuiping Song,
  • Weiwei Liu and
  • Chan Ding
  • + 2 authors

1 November 2019

Infectious bronchitis (IB) and Newcastle disease (ND) are two major infectious diseases that are a threat to the domestic poultry industry. In this study, we successfully generated a recombinant LaSota candidate vaccine strain, rNDV-IBV-T/B, which ex...

(This article belongs to the Section Veterinary Vaccines)
  • Article
  • Open Access
3 Citations
3,342 Views
15 Pages

Intranasal Administration of Recombinant Newcastle Disease Virus Expressing SARS-CoV-2 Spike Protein Protects hACE2 TG Mice against Lethal SARS-CoV-2 Infection

  • Deok-Hwan Kim,
  • Jiho Lee,
  • Da-Ye Lee,
  • Seung-Hun Lee,
  • Jei-Hyun Jeong,
  • Ji-Yun Kim,
  • Jiwon Kim,
  • Yang-Kyu Choi,
  • Joong-Bok Lee and
  • Chang-Seon Song
  • + 4 authors

16 August 2024

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), emerged as a global outbreak in 2019, profoundly affecting both human health and the global economy. Various vaccine modalities were develope...

  • Article
  • Open Access
5 Citations
3,064 Views
17 Pages

Newcastle Disease Virus Expressing Cap Gene of Porcine Circovirus Type 2 Confers Protection in Mice and Induced Long-Lasting Neutralizing Antibodies in Pigs

  • Sohini Dey,
  • Rudhreswaran Murugasamy,
  • Lukumoni Buragohain,
  • Ajai Lawrence D’silva,
  • Jayashree Sarma,
  • Arpita Bharali,
  • Saravanan Ramakrishnan,
  • Mani Saminathan,
  • Nagendra Nath Barman and
  • Madhan Mohan Chellappa
  • + 1 author

15 November 2024

Background/Objectives: Porcine Circovirus 2 (PCV2) infection poses significant health and economic challenges to the global swine industry. The disease in pigs leads to lymphoid depletion, resulting in immunosuppression and increased susceptibility t...

(This article belongs to the Special Issue Strategies of Viral Vectors for Vaccine Development)
  • Review
  • Open Access
29 Citations
7,417 Views
22 Pages

6 May 2022

The COVID-19 pandemic has highlighted the need for efficient vaccine platforms that can rapidly be developed and manufactured on a large scale to immunize the population against emerging viruses. Viral-vectored vaccines are prominent vaccine platform...

(This article belongs to the Special Issue Newcastle Disease Virus and Other Avian Paramyxoviruses)
  • Article
  • Open Access
2 Citations
8,945 Views
18 Pages

The Validation of a Hemagglutination Inhibition Assay That Detects Antibodies Against a Newcastle Disease Virus-Based Vaccine Vector in Human Serum Samples

  • Milton Nieto-Ponce,
  • Edgar Reyna-Rosas,
  • Rosa Andrea Palencia-Reyes,
  • Carlos Blancas-Ruíz,
  • Guadalupe Aguilar-Rafael,
  • Marlenne Paola Rubicer Rubio-Diaz,
  • Luis Alfonso Ramírez-Martínez,
  • Claudia Carranza,
  • Bernardo Lozano-Dubernard and
  • Horacio Zamudio-Meza
  • + 1 author

22 March 2025

Background: An NDV-based vector has been used as a veterinary vaccine and, recently, as a human COVID-19 vaccine. However, data for the potential immune response against the vector in humans are scarce; therefore, it is important to evaluate the leve...

(This article belongs to the Section Vaccine Advancement, Efficacy and Safety)
  • Article
  • Open Access
27 Citations
7,663 Views
16 Pages

Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension Cultures

  • Julia Puppin Chaves Fulber,
  • Omar Farnós,
  • Sascha Kiesslich,
  • Zeyu Yang,
  • Shantoshini Dash,
  • Leonardo Susta,
  • Sarah K. Wootton and
  • Amine A. Kamen

16 November 2021

The ongoing COVID-19 pandemic drew global attention to infectious diseases, attracting numerous resources for development of pandemic preparedness plans and vaccine platforms—technologies with robust manufacturing processes that can quickly be pivote...

(This article belongs to the Section Influenza Virus Vaccines)
  • Article
  • Open Access
14 Citations
6,057 Views
20 Pages

Newcastle Disease Virus Vectored Chicken Infectious Anaemia Vaccine Induces Robust Immune Response in Chickens

  • Madhan Mohan Chellappa,
  • Sohini Dey,
  • Dinesh Chandra Pathak,
  • Asmita Singh,
  • Narayan Ramamurthy,
  • Saravanan Ramakrishnan,
  • Asok Kumar Mariappan,
  • Kuldeep Dhama and
  • Vikram N. Vakharia

2 October 2021

Newcastle disease virus (NDV) strain R2B, with an altered fusion protein cleavage site, was used as a viral vector to deliver the immunogenic genes VP2 and VP1 of chicken infectious anaemia virus (CIAV) to generate a bivalent vaccine candidate agains...

(This article belongs to the Special Issue Newcastle Disease Virus)
  • Article
  • Open Access
3 Citations
3,334 Views
20 Pages

Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus Macaques

  • Bryce M. Warner,
  • Mable Chan,
  • Nikesh Tailor,
  • Robert Vendramelli,
  • Jonathan Audet,
  • Courtney Meilleur,
  • Thang Truong,
  • Lauren Garnett,
  • Marnie Willman and
  • Darwyn Kobasa
  • + 15 authors

10 April 2024

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged following an outbreak of unexplained viral illness in China in late 2019. Since then, it has spread globally causing a pandemic that has resulted in millions of deaths and has had e...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Article
  • Open Access
497 Views
14 Pages

14 September 2026

Newcastle disease virus-like particles (NDVLPs) assemble from the matrix (M), nucleoprotein (NP), fusion (F) and hemagglutinin–neuraminidase (HN) proteins. Terminal epitope tags make these proteins easy to detect but may interfere with assembly...

(This article belongs to the Special Issue Viruses as Therapeutic Tools: Medical and Biotechnological Applications)
  • Article
  • Open Access
2 Citations
678 Views
19 Pages

Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults

  • Kriengkrai Prasert,
  • Sutthichai Nakphook,
  • Jiraphut Kittiwatanachod,
  • Kanlaya Sornwong,
  • Suriya Naosri,
  • Passakorn Ongarj,
  • Isariya Techatanawat,
  • Piengthong Narakorn,
  • Somchaiya Surichan and
  • Prabda Praphasiri
  • + 9 authors

Background/Objectives: HXP-GPOVac is a locally produced, inactivated Newcastle disease virus-based (NDV-HXP-S) COVID-19 vaccine manufactured in Thailand. This phase II trial compared its safety and immunogenicity with the mRNA vaccine BNT162b2 in adu...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Review
  • Open Access
28 Citations
11,969 Views
27 Pages

Current Status of Poultry Recombinant Virus Vector Vaccine Development

  • Haoran Wang,
  • Jiaxin Tian,
  • Jing Zhao,
  • Ye Zhao,
  • Huiming Yang and
  • Guozhong Zhang

Inactivated and live attenuated vaccines are the mainstays of preventing viral poultry diseases. However, the development of recombinant DNA technology in recent years has enabled the generation of recombinant virus vector vaccines, which have the ad...

  • Review
  • Open Access
41 Citations
8,471 Views
23 Pages

Exploring the Prospects of Engineered Newcastle Disease Virus in Modern Vaccinology

  • Muhammad Bashir Bello,
  • Khatijah Yusoff,
  • Aini Ideris,
  • Mohd Hair-Bejo,
  • Abdurrahman Hassan Jibril,
  • Ben P. H. Peeters and
  • Abdul Rahman Omar

16 April 2020

Many traditional vaccines have proven to be incapable of controlling newly emerging infectious diseases. They have also achieved limited success in the fight against a variety of human cancers. Thus, innovative vaccine strategies are highly needed to...

(This article belongs to the Special Issue The Application of Viruses to Biotechnology)
  • Review
  • Open Access
9 Citations
3,237 Views
14 Pages

Oncolytic Viruses in Glioblastoma: Clinical Progress, Mechanistic Insights, and Future Therapeutic Directions

  • Jiayu Liu,
  • Yuxin Wang,
  • Shichao Su,
  • Gang Cheng,
  • Hulin Zhao,
  • Junzhao Sun,
  • Guochen Sun,
  • Fangye Li,
  • Rui Hui and
  • Jianning Zhang
  • + 11 authors

10 December 2025

High-grade gliomas—particularly glioblastoma (GBM)—remain refractory to standard-of-care surgery followed by chemoradiation, with a median overall survival of ~15 months. Oncolytic viruses (OVs), which selectively infect and lyse tumor ce...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
26 Citations
7,925 Views
20 Pages

Viral Vector-Based Melanoma Gene Therapy

  • Altijana Hromic-Jahjefendic and
  • Kenneth Lundstrom

Gene therapy applications of oncolytic viruses represent an attractive alternative for cancer treatment. A broad range of oncolytic viruses, including adenoviruses, adeno-associated viruses, alphaviruses, herpes simplex viruses, retroviruses, lentivi...

(This article belongs to the Section Gene and Cell Therapy)
  • Review
  • Open Access
40 Citations
8,162 Views
20 Pages

Newcastle disease (ND) is one of the most important diseases of poultry worldwide. In the last decades, molecular research has gained a lot of new information about its causative agent, newcastle disease virus (NDV). In poultry industry, certain stra...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
15 Citations
5,552 Views
19 Pages

Novel Recombinant Newcastle Disease Virus-Based In Ovo Vaccines Bypass Maternal Immunity to Provide Full Protection from Early Virulent Challenge

  • Kiril M. Dimitrov,
  • Tonya L. Taylor,
  • Valerie C. Marcano,
  • Dawn Williams-Coplin,
  • Timothy L. Olivier,
  • Qingzhong Yu,
  • Robert M. Gogal,
  • David L. Suarez and
  • Claudio L. Afonso

15 October 2021

Newcastle disease (ND) is one of the most economically important poultry diseases. Despite intensive efforts with current vaccination programs, this disease still occurs worldwide, causing significant mortality even in vaccinated flocks. This has bee...

(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)
  • Review
  • Open Access
4 Citations
5,202 Views
11 Pages

Advances in DNA- and RNA-Based Oncolytic Viral Therapeutics and Immunotherapies

  • Peter Anto Johnson,
  • Alyssa Wu,
  • John Christy Johnson,
  • Zachary Schauer,
  • Terrence Wu,
  • Francis Fernandes,
  • Reinette Schabert and
  • Austin Mardon

The role of viruses has been studied extensively for use as curative cancer therapies. However, the natural immunogenicity of viruses and their interaction with the host’s immune system needs to be examined to determine the full effectiveness o...

  • Article
  • Open Access
357 Views
21 Pages

Combined Vaccination with Recombinant HVT-ND and Live Newcastle Disease Vaccines Accelerates Early Immunity, Limits Virus Shedding and Reduces Transmission

  • Edit Kovács,
  • Tímea Tatár-Kis,
  • Balázs Felföldi,
  • Zalán G. Homonnay,
  • István Kiss,
  • Krisztián Bányai and
  • Vilmos Palya

28 September 2026

Background/Objectives: Effective control of Newcastle disease (ND) requires a reduction in virus shedding and transmission. While recombinant herpesvirus of turkey vectored Newcastle disease (rHVT-ND) vaccines induce strong systemic immunity, their a...

(This article belongs to the Special Issue Poultry Vaccination and Vaccines)
  • Article
  • Open Access
34 Citations
7,520 Views
17 Pages

Development of an Effective and Stable Genotype-Matched Live Attenuated Newcastle Disease Virus Vaccine Based on a Novel Naturally Recombinant Malaysian Isolate Using Reverse Genetics

  • Muhammad Bashir Bello,
  • Siti Nor Azizah Mahamud,
  • Khatijah Yusoff,
  • Aini Ideris,
  • Mohd Hair-Bejo,
  • Ben P. H. Peeters and
  • Abdul Rahman Omar

Genotype VII Newcastle disease viruses are associated with huge economic losses in the global poultry industry. Despite the intensive applications of vaccines, disease outbreaks caused by those viruses continue to occur frequently even among the vacc...

(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)
  • Article
  • Open Access
1 Citations
2,674 Views
14 Pages

Development of a Novel Chimeric ND-GP cVLPs Vaccine for the Prevention of Goose-Derived Newcastle Disease and Gosling Plague

  • Jindou Li,
  • Jiaxin Ding,
  • Chunhong Guo,
  • Xiaohong Xu,
  • Chunhui Shan,
  • Jing Qian and
  • Zhuang Ding

Goose-derived Newcastle disease (ND) and gosling plague (GP) are serious threats to the goose industry. Conventional vaccines have made significant contributions to preventing GP and ND. Nevertheless, the renewal of conventional vaccines and the appl...

(This article belongs to the Topic Advances in Vaccines and Antimicrobial Therapy)
  • Feature Paper
  • Article
  • Open Access
37 Citations
7,124 Views
15 Pages

5 December 2019

Infectious laryngotracheitis virus (ILTV) is a promising vaccine vector due to its heterologous gene accommodation capabilities, low pathogenicity, and potential to induce cellular and humoral arms of immunity. Owing to these characteristics, differe...

(This article belongs to the Special Issue Herpesvirus Vaccines)
  • Article
  • Open Access
10 Citations
5,997 Views
22 Pages

16 September 2020

The recombinant herpesvirus of turkey (rHVT) vaccines targeting Newcastle disease (ND) and H5Nx avian influenza (AI) have been demonstrated efficient in chickens when used individually at day-old. Given the practical field constraints associated with...

(This article belongs to the Special Issue Poultry Vaccines)
  • Article
  • Open Access
7 Citations
3,939 Views
14 Pages

In Vivo Production of HN Protein Increases the Protection Rates of a Minicircle DNA Vaccine against Genotype VII Newcastle Disease Virus

  • Zhannan Wang,
  • Xiaohan Zhao,
  • Ying Wang,
  • Chao Sun,
  • Ming Sun,
  • Xingyun Gao,
  • Futing Jia,
  • Chenxin Shan,
  • Guilian Yang and
  • Yanlong Jiang
  • + 6 authors

The Cre-recombinase mediated in vivo minicircle DNA vaccine platform (CRIM) provided a novel option to replace a traditional DNA vaccine. To further improve the immune response of our CRIM vaccine, we designed a dual promoter expression plasmid named...

(This article belongs to the Special Issue Vaccines against Infectious Diseases and Cancer)
  • Review
  • Open Access
69 Citations
12,615 Views
24 Pages

1 March 2019

RNA viruses have been subjected to substantial engineering efforts to support gene therapy applications and vaccine development. Typically, retroviruses, lentiviruses, alphaviruses, flaviviruses rhabdoviruses, measles viruses, Newcastle disease virus...

(This article belongs to the Section Microbial Genetics and Genomics)
  • Review
  • Open Access
23 Citations
11,424 Views
31 Pages

Biosecurity Implications, Transmission Routes and Modes of Economically Important Diseases in Domestic Fowl and Turkey

  • László Kovács,
  • Gerda Domaföldi,
  • Pia-Charlotte Bertram,
  • Máté Farkas and
  • László Péter Könyves

21 April 2025

The poultry industry is a critical source of affordable protein worldwide; however, it faces continuous threats from various poultry diseases that significantly impact public health, economic stability, and food security. Knowledge of and examination...

  • Article
  • Open Access
14 Citations
5,374 Views
12 Pages

Efficacy of a Turkey Herpesvirus Vectored Newcastle Disease Vaccine against Genotype VII.1.1 Virus: Challenge Route Affects Shedding Pattern

  • Vilmos Palya,
  • Tímea Tatár-Kis,
  • Abdel Satar A. Arafa,
  • Balázs Felföldi,
  • Tamás Mató and
  • Ahmed Setta

11 January 2021

The control of Newcastle disease (ND) highly relies on vaccination. Immunity provided by a ND vaccine can be characterized by measuring the level of clinical protection and reduction in challenge virus shedding. The extent of shedding depends a lot o...

(This article belongs to the Special Issue Poultry Vaccines)
  • Article
  • Open Access
2,178 Views
18 Pages

Newcastle Disease Virus Displaying an Ectodomain of Middle East Respiratory Syndrome Coronavirus Spike Protein Elicited Robust Humoral and Cellular Immunity in Mice

  • Jaturawitt Prasopsiri,
  • Kanjana Srisutthisamphan,
  • Benjamas Liwnaree,
  • Juggragarn Jengarn,
  • Jarin Kramyu,
  • Payuda Hansoongnern,
  • Papon Muangsanit,
  • Nathiphat Tanwattana,
  • Challika Kaewborisuth and
  • Nanchaya Wanasen
  • + 2 authors

24 December 2024

Background: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) causes severe respiratory illness in humans and currently lacks an approved vaccine. The Newcastle disease virus (NDV) vector is a well-established, safe, and effective platform for...

(This article belongs to the Section Vaccine Design, Development, and Delivery)
  • Article
  • Open Access
17 Citations
6,117 Views
18 Pages

21 February 2021

The efficacy of an adenovirus-vectored Newcastle disease virus (NDV) vaccine expressing the fusion (F) NDV protein (adeno-F) was evaluated against challenges with virulent heterologous and homologous NDV strains to the F protein. In a preliminary stu...

(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)
  • Article
  • Open Access
13 Citations
3,779 Views
13 Pages

Generation and Evaluation of Recombinant Thermostable Newcastle Disease Virus Expressing the HA of H9N2 Avian Influenza Virus

  • Xiaorong Zhang,
  • Zongyi Bo,
  • Chenchen Meng,
  • Yin Chen,
  • Chengcheng Zhang,
  • Yongzhong Cao and
  • Yantao Wu

13 August 2021

H9N2 avian influenza virus (AIV) has become endemic in many countries, causing great economic losses when co-infected with other pathogens. So far, several live vaccines based on Newcastle disease virus (NDV) vectors expressing influenza hemagglutini...

(This article belongs to the Special Issue Newcastle Disease Virus)
  • Article
  • Open Access
30 Citations
7,453 Views
17 Pages

Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion

  • Noemi García-Romero,
  • Irina Palacín-Aliana,
  • Susana Esteban-Rubio,
  • Rodrigo Madurga,
  • Sergio Rius-Rocabert,
  • Josefa Carrión-Navarro,
  • Jesús Presa,
  • Sara Cuadrado-Castano,
  • Pilar Sánchez-Gómez and
  • Angel Ayuso-Sacido
  • + 2 authors

5 June 2020

Glioblastoma (GBM) is the most aggressive and frequent primary brain tumor in adults with a median overall survival of 15 months. Tumor recurrence and poor prognosis are related to cancer stem cells (CSCs), which drive resistance to therapies. A comm...

(This article belongs to the Section Stem Cells)
  • Article
  • Open Access
6 Citations
4,009 Views
12 Pages

Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken

  • Wenhao Yang,
  • Jing Dai,
  • Jingjing Liu,
  • Mengjiao Guo,
  • Xiaowen Liu,
  • Shunlin Hu,
  • Min Gu,
  • Jiao Hu,
  • Zenglei Hu and
  • Xiaoquan Wang
  • + 4 authors

28 April 2022

Commercial inactivated vaccines against H9N2 avian influenza (AI) have been developed in China since 1990s and show excellent immunogenicity with strong HI antibodies. However, currently approved vaccines cannot meet the clinical demand for a live-ve...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Article
  • Open Access
13 Citations
6,908 Views
20 Pages

A Recombinant Turkey Herpesvirus Expressing the F Protein of Newcastle Disease Virus Genotype XII Generated by NHEJ-CRISPR/Cas9 and Cre-LoxP Systems Confers Protection against Genotype XII Challenge in Chickens

  • Katherine Calderón,
  • Aldo Rojas-Neyra,
  • Brigith Carbajal-Lévano,
  • Luis Luján-Valenzuela,
  • Julio Ticona,
  • Gisela Isasi-Rivas,
  • Angela Montalvan,
  • Manuel Criollo-Orozco,
  • Edison Huaccachi-Gonzáles and
  • Venugopal Nair
  • + 6 authors

11 April 2022

In this study, we developed a new recombinant virus rHVT-F using a Turkey herpesvirus (HVT) vector, expressing the fusion (F) protein of the genotype XII Newcastle disease virus (NDV) circulating in Peru. We evaluated the viral shedding and efficacy...

(This article belongs to the Special Issue Emerging Technologies and Novel Approaches to Veterinary Viral Vaccine Development)
  • Article
  • Open Access
46 Citations
7,364 Views
16 Pages

Early Detection of Avian Diseases Based on Thermography and Artificial Intelligence

  • Mohammad Sadeghi,
  • Ahmad Banakar,
  • Saeid Minaei,
  • Mahdi Orooji,
  • Abdolhamid Shoushtari and
  • Guoming Li

19 July 2023

Non-invasive measures have a critical role in precision livestock and poultry farming as they can reduce animal stress and provide continuous monitoring. Animal activity can reflect physical and mental states as well as health conditions. If any prob...

(This article belongs to the Special Issue Automated Monitoring of Livestock and Poultry with Machine Learning Technology)
  • Article
  • Open Access
7 Citations
2,651 Views
15 Pages

Enhanced Oncolytic Potential of Engineered Newcastle Disease Virus Lasota Strain through Modification of Its F Protein Cleavage Site

  • Zedian Li,
  • Weifeng Qian,
  • Yuhao Zhang,
  • Chengshui Liao,
  • Jian Chen,
  • Ke Ding,
  • Qingzhong Yu,
  • Yanyan Jia and
  • Lei He

Newcastle disease virus (NDV) is an oncolytic virus whose F protein cleavage activity is associated with viral infectivity. To explore the potential of modifying F protein cleavage activity to enhance antitumor effects, we constructed a recombinant N...

(This article belongs to the Section Virology)

of 2